Origin Life Sciences, Inc. — Form D

Origin Life Sciences, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-07. The offering totals $5.0M, of which $500K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Tony David BramptonDirectorPrinceton, NJ
Vic David MicatiDirectorPrinceton, NJ
Howard David NelsonDirectorPrinceton, NJ
Alex David Dolgopolsky, PhDExecutive OfficerPrinceton, NJ
Johnny David FernandesExecutive OfficerPrinceton, NJ
Mike David PohlExecutive OfficerPrinceton, NJ
Michael David PrestonDirectorPrinceton, NJ
Michael David PrestonExecutive OfficerPrinceton, NJ
Jerome Boda KortenDirectorPrinceton, NJ
Victor David MicatiDirectorPrinceton, NJ
David David DantzkerDirectorPrinceton, NJ
David David DantzkerExecutive OfficerPrinceton, NJ
John David FernandesExecutive OfficerPrinceton, NJ
Anthony David BramptonDirectorPrinceton, NJ
Howard David NelsonExecutive OfficerPrinceton, NJ
David David Dantzker, MDDirectorPrinceton, NJ
David David Dantzker, MDExecutive OfficerPrinceton, NJ
Betsy David HannaExecutive OfficerPrinceton, NJ
Michael David PohlExecutive OfficerLawrenceville, NJ
Alex David Dolgopolsky, MDExecutive OfficerLawrenceville, NJ
Issac David Anthony IIIExecutive OfficerLawrenceville, NJ

Other filings by this issuer (5)

FiledFormOfferingSold
2023-10-17D$5.0M$51K
2023-06-22D/A$850K$660K
2023-06-01D$850K$500K
2017-05-15D$22.5M$1.3M
2013-04-08D$2.5M$500K

More